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Objective: To evaluate mid-term clinical outcomes of inter-
spinous spacer treatment in patients with intermittent neurogenic
claudication secondary to radiographically confirmed moderate
LSS.
Design: Prospective, randomized, controlled, investigational
device exemption (IDE) trial.
Setting: 23 hospitals in the United States.
Participants: 145 patients with intermittent neurogenic claudi-
cation secondary to moderate LSS and unresponsive to conservative
care.
Interventions: Patients were randomly treated with interspinous
spacer implant (Superion 75; X-Stop 70) and followed for 18
months.
Main OutcomeMeasures: Zurich Claudication Questionnaire
(ZCQ), axial and extremity pain on a 0 to 100 scale, and Oswestry
Disability Index (ODI).
Results or Clinical Course: ZCQ symptom severity and
physical function scores improved 33% to 36% in both groups
through 18 months (all p<.001). ZCQ patient satisfaction scores
at 18 months were 1.70.8 with Superion and 1.60.7 with X-
STOP. Axial pain decreased from 5528 mm at pre-treatment to
2326 mm at 18 months in the Superion group (p<.001) and
from 5527 mm to 2628 mm with X-STOP (p<.001)
(p¼0.28 between groups). Extremity pain decreased from
6724 mm at pre-treatment to 2028 mm at 18 months with
Superion (p<.001) and from 6824 mm to 2228 mm with X-
STOP (p<.001) (p¼.71 between groups). Back function simi-
larly improved with Superion (3913% to 1915%; p<.001)
vs. X-STOP (4012% to 2017%; p<.001) (p¼.46 between
groups).
Conclusions: Clinical improvements in axial and extremity
pain and function are similarly maintained through 18 months
post-treatment with the Superion and X-Stop interspinous
spacers.Poster 432
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Objective: The purpose of this study is to identify relationships
between clinical predictors and medical interventions utilized for
patients admitted to the emergency department with a complaint of
low back pain.Design: This is a prospective analysis of the medical records for
400 total patients admitted to an emergency department with
a diagnosis with low back pain.
Setting: A level-one university trauma center and a large
community hospital emergency department.
Participants: Medical records from 200 consecutive patients ages
18-80 admitted through the two participating emergency depart-
ments with a diagnosis code consistent for low back pain.
Interventions: Secondary data collection with medical chart
review and data abstraction from existing records.
Main Outcome Measures: Analysis of patient demographics,
nature of pain complaints and the diagnosis were correlated for
relationships to the diagnostic tests ordered, medications prescribed
and the discharge recommendations.
Results or Clinical Course: Medical record analysis of the 369
total patients that met inclusion criteria demonstrated a mean age of
42.73 years old with female 56.08% and Caucasian 65.58%. The
insurance coverage for these patients included commercial 39.83%,
Medicaid 21.12%, none 20.6%, Medicare 13.0% and personal
injury 5.42%. In 81.61% of patients the symptoms started within
one week. Patients reported severe pain in 23.17% and radicular
symptoms in 26.45%. Red flags were identified in 57.68% with
yellow flags in 77.08%. The physical examination showed 12.09%
of patients demonstrated any neurologic signs. Imaging studies
were ordered in 47.61% of the patients with plain x-rays 36.73%,
CT 10.33% and MRI 6.55%. Patients were discharged with opiates
53.15%, NSAIDs 36.27%, muscle relaxers 24.69%, acetaminophen
18.64%, activity restrictions 12.09% and educational handouts in
47.36%. Pending regression and post-hoc analysis.
Conclusions: Anticipated Conclusion: Emergency department
physicians generally do not utilize evidence-based guidelines in the
evaluation and management of low back pain.
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Objective: To establish the minimum number of interlaminar
cervical epidural steroid injections needed for inexperienced pain
fellowship trainees to obtain professional competency through the
utilization of fluoroscopy procedural times as the primary
benchmark.
Design: A prospective descriptive study.
Setting: Major research University based outpatient procedure
clinic.
Participants: 4 experienced and 4 inexperienced PM&R Pain
Fellows with attending supervision.
Interventions: Fluoroscopy procedural exposure time (FT) was
determined and analyzed for interlaminar cervical epidural steroid
injections (ICESI). Procedures were grouped by spinal level and the
trainee’s experience level.
Main Outcome Measures: Trainees were stratified according
to experience level: fellows completing year-long training (T1)
and fellows beginning year-long training (T2). T1 FT was used as
the benchmark with a single attending FT as a control group. T1
